272 related articles for article (PubMed ID: 28941939)
1. Complete functional characterization of disease-associated genetic variants in the complement factor H gene.
Merinero HM; García SP; García-Fernández J; Arjona E; Tortajada A; Rodríguez de Córdoba S
Kidney Int; 2018 Feb; 93(2):470-481. PubMed ID: 28941939
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration.
Geerlings MJ; Volokhina EB; de Jong EK; van de Kar N; Pauper M; Hoyng CB; van den Heuvel LP; den Hollander AI
Clin Genet; 2018 Oct; 94(3-4):330-338. PubMed ID: 29888403
[TBL] [Abstract][Full Text] [Related]
3. Factor H Autoantibodies and Complement-Mediated Diseases.
Zhang Y; Ghiringhelli Borsa N; Shao D; Dopler A; Jones MB; Meyer NC; Pitcher GR; Taylor AO; Nester CM; Schmidt CQ; Smith RJH
Front Immunol; 2020; 11():607211. PubMed ID: 33384694
[TBL] [Abstract][Full Text] [Related]
4. A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.
Ding Y; Zhao W; Zhang T; Qiang H; Lu J; Su X; Wen S; Xu F; Zhang M; Zhang H; Zeng C; Liu Z; Chen H
Sci Rep; 2017 Jul; 7(1):6004. PubMed ID: 28729648
[TBL] [Abstract][Full Text] [Related]
5. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification.
Martín Merinero H; Zhang Y; Arjona E; Del Angel G; Goodfellow R; Gomez-Rubio E; Ji RR; Michelena M; Smith RJH; Rodríguez de Córdoba S
Blood; 2021 Dec; 138(22):2185-2201. PubMed ID: 34189567
[TBL] [Abstract][Full Text] [Related]
7. Genetic and Protein Structural Evaluation of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Perkins SJ
Adv Chronic Kidney Dis; 2020 Mar; 27(2):120-127.e4. PubMed ID: 32553244
[TBL] [Abstract][Full Text] [Related]
8. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
[TBL] [Abstract][Full Text] [Related]
9. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
Front Immunol; 2019; 10():853. PubMed ID: 31118930
[TBL] [Abstract][Full Text] [Related]
10. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele
Pouw RB; Gómez Delgado I; López Lera A; Rodríguez de Córdoba S; Wouters D; Kuijpers TW; Sánchez-Corral P
Front Immunol; 2018; 9():848. PubMed ID: 29740447
[TBL] [Abstract][Full Text] [Related]
11. Complement Factor I Variants in Complement-Mediated Renal Diseases.
Zhang Y; Goodfellow RX; Ghiringhelli Borsa N; Dunlop HC; Presti SA; Meyer NC; Shao D; Roberts SM; Jones MB; Pitcher GR; Taylor AO; Nester CM; Smith RJH
Front Immunol; 2022; 13():866330. PubMed ID: 35619721
[TBL] [Abstract][Full Text] [Related]
12. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome.
Bu F; Zhang Y; Wang K; Borsa NG; Jones MB; Taylor AO; Takanami E; Meyer NC; Frees K; Thomas CP; Nester C; Smith RJH
J Am Soc Nephrol; 2018 Dec; 29(12):2809-2819. PubMed ID: 30377230
[TBL] [Abstract][Full Text] [Related]
13. Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD.
Wong EKS; Hallam TM; Brocklebank V; Walsh PR; Smith-Jackson K; Shuttleworth VG; Cox TE; Anderson HE; Barlow PN; Marchbank KJ; Harris CL; Kavanagh D
Front Immunol; 2020; 11():602284. PubMed ID: 33519811
[TBL] [Abstract][Full Text] [Related]
14. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.
Goicoechea de Jorge E; Tortajada A; García SP; Gastoldi S; Merinero HM; García-Fernández J; Arjona E; Cao M; Remuzzi G; Noris M; Rodríguez de Córdoba S
J Am Soc Nephrol; 2018 Jan; 29(1):240-249. PubMed ID: 28993505
[TBL] [Abstract][Full Text] [Related]
15. Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases.
Michels MAHM; van de Kar NCAJ; Okrój M; Blom AM; van Kraaij SAW; Volokhina EB; van den Heuvel LPWJ
Front Immunol; 2018; 9():612. PubMed ID: 29670616
[TBL] [Abstract][Full Text] [Related]
16. Genetic abnormalities in biopsy-proven, adult-onset hemolytic uremic syndrome and C3 glomerulopathy.
Haydock L; Garneau AP; Tremblay L; Yen HY; Gao H; Harrisson R; Isenring P
J Mol Med (Berl); 2022 Feb; 100(2):269-284. PubMed ID: 34714369
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z
Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
[TBL] [Abstract][Full Text] [Related]
18. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
[TBL] [Abstract][Full Text] [Related]
19. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Goodship TH; Cook HT; Fakhouri F; Fervenza FC; Frémeaux-Bacchi V; Kavanagh D; Nester CM; Noris M; Pickering MC; Rodríguez de Córdoba S; Roumenina LT; Sethi S; Smith RJ;
Kidney Int; 2017 Mar; 91(3):539-551. PubMed ID: 27989322
[TBL] [Abstract][Full Text] [Related]
20. Unraveling the Effect of a Potentiating Anti-Factor H Antibody on Atypical Hemolytic Uremic Syndrome-Associated Factor H Variants.
Dekkers G; Brouwer MC; Jeremiasse J; Kamp A; Biggs RM; van Mierlo G; Lauder S; Katti S; Kuijpers TW; Rispens T; Jongerius I
J Immunol; 2020 Oct; 205(7):1778-1786. PubMed ID: 32848031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
